Results 41 to 50 of about 47,296 (185)

Inner Retinal Thickness and Vasculature in Patients with Reticular Pseudodrusen

Ophthalmic Research, 2023
Introduction: The aim of this study was to investigate retinal layer thickness and vessel density differences between patients with reticular pseudodrusen (RPD) and intermediate dry age-related macular degeneration (iAMD).
F. Kalaw, Varsha Alex, Evan Walker, D. Bartsch, W. R. Freeman, S. Borooah   +5 more
semanticscholar   +3 more sources

Choroidal vascularity index in leptochoroid: A comparative analysis between reticular pseudodrusen and high myopia. [PDF]

Eye (Lond), 2023
Sacconi R, Borrelli E, Balasubramanian S, Vella G, Battista M, Vupparaboina KK, Chhablani J, Bandello F, Querques G.   +8 more
europepmc   +2 more sources

Reticular Pseudodrusen in Late-Onset Retinal Degeneration. [PDF]

Ophthalmol Retina, 2021
To characterize the association of reticular pseudodrusen (RPD) with late-onset retinal degeneration (L-ORD) using multimodal imaging.Prospective, 2-center, longitudinal case series.Twenty-nine patients with L-ORD.All patients were evaluated within a 3-year interval with near-infrared reflectance, fundus autofluorescence, and spectral-domain OCT.
Borooah S, Papastavrou V, Lando L, Han J, Lin JH, Ayyagari R, Dhillon B, Browning AC.   +7 more
europepmc   +6 more sources

Drusen-specific dark adaptation profiles in intermediate age-related macular degeneration [PDF]

International Journal of Retina and Vitreous
Aims To investigate the influence of macular drusen phenotypes on dark adaptation (DA) in intermediate age-related macular degeneration (iAMD). Methods This cross-sectional, multicentric study enrolled 57 eyes of 43 iAMD patients.
Paolo Forte, Lorenzo Ferro Desideri, Marco Nassisi, Federica Milanesi, Alessandro Feo, Irene Bagnasco, Sharlot M. Iglesia, Giovanni Forte, Davide Scandella, Fabiola Roccatagliata, Vincenzo Fontana, Chiara Maria Eandi, Michele Iester, Jasleen K. Jolly, Martin S. Zinkernagel, Francesco Viola, Massimo Nicolò   +16 more
doaj   +2 more sources

Unaffected fellow eye neovascularization in patients with type 3 neovascularization: Incidence and risk factors.

PLoS ONE, 2021
PurposeTo evaluate the incidence and risk factors of neovascularization in unaffected fellow eyes of patients diagnosed with type 3 neovascularization in Korea.MethodsThis retrospective study included 93 unaffected fellow eyes of 93 patients diagnosed ...
Jae Hyuck Kwak, Woo Kyung Park, Rae Young Kim, Mirinae Kim, Young-Gun Park, Young-Hoon Park   +5 more
doaj   +1 more source

Deficits in Monocyte Function in Age Related Macular Degeneration: A Novel Systemic Change Associated With the Disease

Frontiers in Medicine, 2021
Age-related macular degeneration (AMD) is characterized by the accumulation of debris in the posterior eye. In this study we evaluated peripheral blood monocyte phagocytic function at various stages of AMD and in aged matched control participants.
Ben J. Gu, Ben J. Gu, Xin Huang, Pavan K. Avula, Emily Caruso, Candace Drysdale, Kirstan A. Vessey, Amber Ou, Christopher Fowler, Tian-Hua Liu, Yong Lin, Adam Horton, Colin L. Masters, James S. Wiley, Robyn H. Guymer, Erica L. Fletcher   +15 more
doaj   +1 more source

Evolution of reticular pseudodrusen [PDF]

British Journal of Ophthalmology, 2010
To report observations relating to the clinical recognition and possible basis of reticular pseudodrusen (RPD).This retrospective study reports the evolution of RPD in 166 patients who had follow-up of over 1 year using multiple imaging techniques. Mean age when first seen was 73.3 years and the mean period of observation was 4.9 years (range 1-18 ...
John, Sarks, Jennifer, Arnold, I-Van, Ho, Shirley, Sarks, Murray, Killingsworth   +4 more
openaire   +2 more sources

Multimodal imaging and deep learning in geographic atrophy secondary to age‐related macular degeneration

Acta Ophthalmologica, Volume 101, Issue 8, Page 881-890, December 2023., 2023
Abstract Geographic atrophy (GA) secondary to age‐related macular degeneration is among the most common causes of irreversible vision loss in industrialized countries. Recently, two therapies have been approved by the US FDA. However, given the nature of their treatment effect, which primarily involves a relative decrease in disease progression ...
Maximilian Pfau, Sandrine H. Künzel, Kristina Pfau, Steffen Schmitz‐Valckenberg, Monika Fleckenstein, Frank G. Holz   +5 more
wiley   +1 more source

Treatment of dry age‐related macular degeneration: A review

Clinical &Experimental Ophthalmology, Volume 51, Issue 8, Page 835-852, November 2023., 2023
Abstract Age‐related macular degeneration is a global disease with a significant societal impact. The advent of anti‐vascular endothelial growth factor therapy (anti‐VEGF) has revolutionised the treatment of neovascular age‐related macular degeneration (nAMD).
Shenouda Girgis, Lawrence R. Lee
wiley   +1 more source

Optometrists' attitudes toward using OCT angiography lag behind other retinal imaging types

Ophthalmic and Physiological Optics, Volume 43, Issue 4, Page 905-915, July 2023., 2023
Abstract Purpose While optometrists' attitudes toward established retinal imaging types are generally positive, they are unknown for optical coherence tomography angiography (OCTA). We performed a cross‐sectional survey to estimate attitudes toward OCTA and identify clinician and/or practice characteristics that influence them.
Rene Cheung, Sharon Ho, Angelica Ly
wiley   +1 more source